Published in Int J Mol Sci on March 25, 2013
Important molecular genetic markers of colorectal cancer. Oncotarget (2016) 0.94
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. J Immunol (2014) 0.89
Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation. Cell Cycle (2015) 0.82
Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model. Cancer Biol Ther (2015) 0.77
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? Br J Pharmacol (2015) 0.77
COX-2 induces lytic reactivation of EBV through PGE2 by modulating the EP receptor signaling pathway. Virology (2015) 0.77
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience (2016) 0.76
The whipworm (Trichuris suis) secretes prostaglandin E2 to suppress proinflammatory properties in human dendritic cells. FASEB J (2016) 0.75
Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis. Front Microbiol (2017) 0.75
Expression of prostaglandin E2 prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma - preliminary study. Contemp Oncol (Pozn) (2015) 0.75
Editorial of the special issue: signaling molecules and signal transduction in cells. Int J Mol Sci (2013) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Seven-transmembrane receptors. Nat Rev Mol Cell Biol (2002) 11.50
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature (2007) 7.55
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell (2010) 5.28
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev (1994) 5.11
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell (2009) 4.69
Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 4.28
Regulation of immune responses by prostaglandin E2. J Immunol (2012) 3.93
Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci (2006) 3.69
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol (2007) 3.42
Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol (1997) 2.81
Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev (2007) 2.75
Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood (2009) 2.73
Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med (2009) 2.68
IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol (1997) 2.67
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood (2002) 2.61
Cytoskeletal control of CD36 diffusion promotes its receptor and signaling function. Cell (2011) 2.57
Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med (2009) 2.41
Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem (2001) 2.41
Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat (2002) 2.36
How chemokines invite leukocytes to dance. Nat Immunol (2008) 2.18
Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci U S A (1999) 2.15
Prostanoid biosynthesis and mechanisms of action. Am J Physiol (1992) 2.05
Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell (2011) 2.04
Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem (2003) 1.89
Some interfaces of dendritic cell biology. APMIS (2003) 1.79
Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med (2003) 1.78
In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol (2008) 1.63
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem (1993) 1.61
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol Pharmacol (1994) 1.56
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A (2002) 1.51
Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol (2006) 1.40
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood (2007) 1.38
A critical role for prostaglandin E2 in podosome dissolution and induction of high-speed migration during dendritic cell maturation. J Immunol (2006) 1.37
beta-Bungarotoxin, a pre-synaptic toxin with enzymatic activity. Proc Natl Acad Sci U S A (1976) 1.36
Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med (2003) 1.32
NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des (2006) 1.31
Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol Pharmacol (2005) 1.28
Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem (1999) 1.27
Organization of the integrin LFA-1 in nanoclusters regulates its activity. Mol Biol Cell (2006) 1.26
Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Mol Pharmacol (2000) 1.25
Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol (2009) 1.23
Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. J Biol Chem (2001) 1.20
PGE2-mediated podosome loss in dendritic cells is dependent on actomyosin contraction downstream of the RhoA-Rho-kinase axis. J Cell Sci (2008) 1.18
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood (2009) 1.18
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. Cancer Immunol Immunother (2008) 1.15
Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation. J Biol Chem (2011) 1.13
Actin cytoskeleton-dependent dynamics of the human serotonin1A receptor correlates with receptor signaling. Biophys J (2008) 1.12
Prostaglandin E2 and T cells: friends or foes? Immunol Cell Biol (2011) 1.12
EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol Pharmacol (2005) 1.08
Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem (2002) 1.08
Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc Natl Acad Sci U S A (2003) 1.07
LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. Carcinogenesis (2013) 1.06
Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv Exp Med Biol (1997) 1.06
Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury. Stem Cells (2013) 1.05
Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells. Cell Immunol (2001) 1.04
Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells. Blood (2008) 1.04
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. J Leukoc Biol (2007) 1.01
Prostaglandin E receptor EP1 controls impulsive behavior under stress. Proc Natl Acad Sci U S A (2005) 1.01
Prostanoids in immunity: roles revealed by mice deficient in their receptors. Life Sci (2003) 1.01
Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. J Pharmacol Exp Ther (2009) 1.01
Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement. J Immunol (2009) 1.00
PPARgamma, a lipid-activated transcription factor as a regulator of dendritic cell function. Ann N Y Acad Sci (2006) 1.00
Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunol Cell Biol (2004) 0.99
Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor. FEBS Lett (2001) 0.96
Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J (2008) 0.96
Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E-receptor subtype EP(3). Gastroenterology (1999) 0.96
A spatially restricted increase in receptor mobility is involved in directional sensing during Dictyostelium discoideum chemotaxis. J Cell Sci (2008) 0.94
Prostaglandin E2: making more of your marrow. Cell Cycle (2007) 0.93
Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells. Immunology (2006) 0.91
Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells. J Biol Chem (2012) 0.88
Prostaglandin E(2) regulates murine hematopoietic stem/progenitor cells directly via EP4 receptor and indirectly through mesenchymal progenitor cells. Blood (2013) 0.88
PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4). Mol Immunol (2013) 0.88
Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood (2011) 0.87
Disrupting microtubule network immobilizes amoeboid chemotactic receptor in the plasma membrane. Biochim Biophys Acta (2011) 0.86
Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide. J Immunol (2006) 0.86
Agonist-induced phosphorylation by G protein-coupled receptor kinases of the EP4 receptor carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor hybrid. Mol Pharmacol (1999) 0.85
TLR4-mediated podosome loss discriminates gram-negative from gram-positive bacteria in their capacity to induce dendritic cell migration and maturation. J Immunol (2009) 0.85
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit. Mol Immunol (2012) 0.85
Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells. Oncoimmunology (2012) 0.85
Sphingosine 1-phosphate as a novel immune regulator of dendritic cells. J Biosci (2007) 0.81
Lipids in dendritic cell biology: messengers, effectors, and antigens. J Leukoc Biol (2006) 0.77
Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med (2009) 5.27
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest (2006) 4.45
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol (2007) 3.42
The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol (2003) 2.30
NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood (2004) 1.88
Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion. Proc Natl Acad Sci U S A (2009) 1.60
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood (2005) 1.57
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res (2003) 1.57
Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J Biol Chem (2008) 1.50
Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J Control Release (2010) 1.32
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells. Blood (2005) 1.30
Organization of the integrin LFA-1 in nanoclusters regulates its activity. Mol Biol Cell (2006) 1.26
Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Oncol (2010) 1.24
DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J Leukoc Biol (2008) 1.22
Skeletal muscle development and regeneration. Stem Cells Dev (2007) 1.17
Lateral mobility of individual integrin nanoclusters orchestrates the onset for leukocyte adhesion. Proc Natl Acad Sci U S A (2012) 1.15
Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev (2010) 1.14
Nanoscale organization of the pathogen receptor DC-SIGN mapped by single-molecule high-resolution fluorescence microscopy. Chemphyschem (2007) 1.10
Interlaboratory round robin on cantilever calibration for AFM force spectroscopy. Ultramicroscopy (2011) 1.08
Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation. Blood (2011) 1.06
Direct mapping of nanoscale compositional connectivity on intact cell membranes. Proc Natl Acad Sci U S A (2010) 1.06
Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun (2009) 1.06
The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity. PLoS Pathog (2009) 1.05
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used. Cancer Immunol Immunother (2010) 1.04
Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells. Arthritis Rheum (2003) 1.04
Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer. Eur J Cancer (2011) 1.03
Targeting antigens to dendritic cells in vivo. Immunobiology (2006) 1.02
Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism. J Immunol (2010) 1.02
Analysis of dendritic cell trafficking using EGFP-transgenic mice. Immunol Lett (2003) 0.98
The tetraspanin CD37 orchestrates the α(4)β(1) integrin-Akt signaling axis and supports long-lived plasma cell survival. Sci Signal (2012) 0.97
A functional model for adult stem cells in epithelial tissues. Wound Repair Regen (2009) 0.94
Harnessing human plasmacytoid dendritic cells as professional APCs. Cancer Immunol Immunother (2012) 0.94
DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. Eur J Immunol (2011) 0.94
Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cells. J Immunol (2008) 0.93
The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cell Oncol (Dordr) (2013) 0.92
Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation. Int J Cancer (2008) 0.92
Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med (2009) 0.92
Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. Microbes Infect (2004) 0.91
Relevance of DC-SIGN in DC-induced T cell proliferation. J Leukoc Biol (2006) 0.91
Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses. Mol Immunol (2011) 0.91
Mesenchymal stem cells respond to TNF but do not produce TNF. J Leukoc Biol (2009) 0.90
Deciphering the message broadcast by tumor-infiltrating dendritic cells. Am J Pathol (2012) 0.90
A nanometer scale optical view on the compartmentalization of cell membranes. Biochim Biophys Acta (2009) 0.89
Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6. J Cell Sci (2014) 0.87
Skeletal muscle fibrosis: the effect of stromal-derived factor-1α-loaded collagen scaffolds. Regen Med (2010) 0.87
In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models. J Immunother (2007) 0.87
Geometry sensing by dendritic cells dictates spatial organization and PGE(2)-induced dissolution of podosomes. Cell Mol Life Sci (2011) 0.87
Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy. J Cell Sci (2007) 0.87
Eradicating cancer cells: struggle with a chameleon. Oncotarget (2011) 0.86
Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions. J Leukoc Biol (2005) 0.86
In vivo targeting of DC-SIGN-positive antigen-presenting cells in a nonhuman primate model. J Immunother (2007) 0.86
Mast cell synapses and exosomes: membrane contacts for information exchange. Front Immunol (2012) 0.86
Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity. Exp Toxicol Pathol (2012) 0.86
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN. Biomaterials (2012) 0.85
Dynamic re-organization of individual adhesion nanoclusters in living cells by ligand-patterned surfaces. Small (2009) 0.85
The neck region of the C-type lectin DC-SIGN regulates its surface spatiotemporal organization and virus-binding capacity on antigen-presenting cells. J Biol Chem (2012) 0.85
"Sweet talk": closing in on C type lectin signaling. Immunity (2005) 0.84
Wnt16 is involved in intramembranous ossification and suppresses osteoblast differentiation through the Wnt/β-catenin pathway. J Cell Physiol (2014) 0.84
Microdomains in the membrane landscape shape antigen-presenting cell function. J Leukoc Biol (2013) 0.83
In vitro migration and adhesion of fibroblasts from different phases of palatal wound healing. Wound Repair Regen (2006) 0.83
Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton. J Biol Chem (2014) 0.83
Interaction of acute lymphopblastic leukemia cells with C-type lectins DC-SIGN and L-SIGN. Exp Hematol (2008) 0.83
No advantage of cell-penetrating peptides over receptor-specific antibodies in targeting antigen to human dendritic cells for cross-presentation. J Immunol (2008) 0.83
In vivo recruitment of hematopoietic cells using stromal cell-derived factor 1 alpha-loaded heparinized three-dimensional collagen scaffolds. Tissue Eng Part A (2009) 0.83
The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells. Immunol Cell Biol (2010) 0.83
Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses. J Immunol (2006) 0.83
Hematopoietic stem cells are coordinated by the molecular cues of the endosteal niche. Stem Cells Dev (2010) 0.82
Automated podosome identification and characterization in fluorescence microscopy images. Microsc Microanal (2013) 0.82
Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2. Stem Cells Dev (2014) 0.82
The recruitment of bone marrow-derived cells to skin wounds is independent of wound size. Wound Repair Regen (2011) 0.82
Fibroblast subpopulations in intra-oral wound healing. Wound Repair Regen (2003) 0.81
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination. Clin Cancer Res (2011) 0.81
Mesenchymal stromal cells: tissue engineers and immune response modulators. Arch Immunol Ther Exp (Warsz) (2008) 0.81
Report on antibodies submitted to the stromal cell section of HLDA8. Cell Immunol (2005) 0.80
An automated multi well cell track system to study leukocyte migration. J Immunol Methods (2003) 0.80
Myogenic capacity of muscle progenitor cells from head and limb muscles. Eur J Oral Sci (2012) 0.80
Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients. Oncoimmunology (2013) 0.79
Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor. Int J Gynecol Cancer (2011) 0.79
The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues. Cancer Immunol Immunother (2011) 0.79
Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking. Eur J Immunol (2012) 0.79
Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome. BMC Immunol (2012) 0.79
IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1. J Invest Dermatol (2010) 0.79
Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin-12 production by mature dendritic cells. Immunology (2009) 0.79
Blood vessels engineered from human cells. Lancet (2005) 0.78
Interleukin-4 alters early phagosome phenotype by modulating class I PI3K dependent lipid remodeling and protein recruitment. PLoS One (2011) 0.78
Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells. Nanomedicine (Lond) (2012) 0.77
Dynamic protein expression patterns during intraoral wound healing in the rat. Eur J Oral Sci (2005) 0.77
Model for muscle regeneration around fibrotic lesions in recurrent strain injuries. Med Sci Sports Exerc (2010) 0.76
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue. Hum Vaccin Immunother (2015) 0.75
Quantifying the efficacy of influenza vaccines. Lancet Infect Dis (2012) 0.75
Aiming to immune elimination of ovarian cancer stem cells. World J Stem Cells (2013) 0.75
Molecular friction as a tool to identify functionalized alkanethiols. Langmuir (2010) 0.75
Binding and uptake of Candida albicans by human monocyte-derived dendritic cells. Methods Mol Biol (2012) 0.75
Binding of the adhesion and pathogen receptor DC-SIGN by monocytes is regulated by the density of Lewis X molecules. Mol Immunol (2006) 0.75
Differentiating stem cells mask their origins. Stem Cells (2004) 0.75